Pharmaceutical Contract Development And Manufacturing Organization (CMO) Industry Valued at $260.83 Billion by 2029 With CAGR of 8.7% | Size and Share Insights
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market from 2024 to 2025?
The market size of the pharmaceutical contract development and manufacturing organization (CMO) has seen a robust expansion in the past few years. It is projected to swell from $174.33 billion in 2024 to $186.62 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.1%. This momentum during the historical duration can be reasoned to vigorous economic development in burgeoning markets, escalated healthcare spending, growth in pharmaceutical research and development (R&D) investment, and a marked inclination for outsourcing.
What Is the Projected Market Size of the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
In the coming years, the market size for the pharmaceutical contract development and manufacturing organization (CMO) is set to experience robust growth, escalating to a valuation of $260.83 billion by 2029 at a compound annual growth rate (CAGR) of 8.7%. The substantial growth projected during the forecast period can be ascribed to several factors such as enhanced government backing, greater healthcare accessibility, more significant investments, and increased biopharmaceutical development propelling the market forward. Highlighted trends for the forecast period encompass a heightened emphasis on sustainability, the integration of artificial intelligence and digitalization, the introduction of innovative products geared towards resilience, and the rise in investments, with strategic partnerships and collaborations becoming increasingly prominent among market participants.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
Who are the Major Competitors in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Outlook?
Major companies operating in the pharmaceutical contract development and manufacturing organization (CMO) market include Lonza Group, Catalent Inc, WuXi AppTec Inc., Pfizer Inc, Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co., Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Boehringer Ingelheim International GmbH, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, AbbVie Inc, Merck & Co Inc, Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Johnson & Johnson, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals
What Is Fueling Growth in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
The pharmaceutical contract development and manufacturing market is experiencing growth due to the surge in global medicine demand. The increased need for a longer lifespan and the high incidence of diseases have led to an increased demand for medication, causing pharmaceutical companies to boost production and invest more in R&D for new drug development. To lower operational expenses, these firms are partnering with contract manufacturing organizations (CMOs), thereby driving demand in the pharmaceutical contract development and manufacturing market. Alkermes PLC., a biopharmaceutical firm, suggests that many companies, both large and small specialist pharma entities, will consider pharmaceutical contract manufacturing as a key strategic approach primarily because these entities are seeking ways to cut costs.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=2825&type=smp
Which Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segments Are Growing the Fastest?
The pharmaceutical contract development and manufacturing organization (CMO) market covered in this report is segmented –
1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
2) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies
Subsegments:
1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services
Which Industry Trends Are Shaping the Future of the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Companies within the pharmaceutical contract development and manufacturing market are adopting investment strategies that involve forming partnerships and acquiring other companies within the same market. The trend of mergers and acquisitions is followed with the aim of broadening their global market presence, enhancing production capacity while being cost-effective, and gaining access to the newest technology and services. This increase in mergers and acquisitions is leading to a consolidation of contract service providers. For instance, Pharma Nobis, a US-based company offering contract manufacturing and private label services, took over Fagron’s U.S contract manufacturing business in July 2022 for an undisclosed sum. This acquisition will enable Pharma Nobis to provide contract manufacturing and private label services to American retailers and consumer healthcare companies. Fagron will still retain 20% ownership of the company.
Access The Full Report Here:
Which Countries Are Leading the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2825
This Report Delivers Insight On:
1. How big is the pharmaceutical contract development and manufacturing organization (cmo) market, and how is it changing globally?
2. Who are the major companies in the pharmaceutical contract development and manufacturing organization (cmo) market, and how are they performing?
3. What are the key opportunities and risks in the pharmaceutical contract development and manufacturing organization (cmo) market right now?
4. Which products or customer segments are growing the most in the pharmaceutical contract development and manufacturing organization (cmo) market?
5. What factors are helping or slowing down the growth of the pharmaceutical contract development and manufacturing organization (cmo) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
